# GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/go-dact-a-phase-3b-randomised-double-blind-placebo-controlled-trial-of-golimumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elsa Vieira‐Sousa,Pedro Augusto Alves,Ana Maria Rodrigues,Filipa Teixeira,José Tavares‐Costa,A. Bernardo,Sofia Pimenta,Fernando Pimentel‐Santos,João Lagoas Gomes,Renata Aguiar,Patrícia Pinto,Taciana Videira,Cristina Catita,Helena Santos,Joana Borges,Graça Sequeira,Célia Ribeiro,Lídia Teixeira,Pedro Ávila-Ribeiro,Fernando Martins,Helena Canhão,Iain B. McInnes,Ruy M. Ribeiro,João Eurico Fonseca |
| Citations | 63 |
| DOI | 10.1136/annrheumdis-2019-216500 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/79/4/490.full.pdf |
| OpenAlex ID | https://openalex.org/W3010828189 |
| PMID | 32193187 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Sofia Pimenta](https://scholariq.org/researchers/sofia-pimenta/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.